• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞来源的 microRNAs 作为肝移植后肝损伤和排斥反应的血清标志物。

Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation.

机构信息

Department of Surgery and Laboratory of Experimental Transplantation and Intestinal Surgery, Erasmus MC: University Medical Center Rotterdam, Rotterdam, the Netherlands.

出版信息

Liver Transpl. 2012 Mar;18(3):290-7. doi: 10.1002/lt.22438.

DOI:10.1002/lt.22438
PMID:21932376
Abstract

Recent animal and human studies have highlighted the potential of hepatocyte-derived microRNAs (HDmiRs) in serum as early, stable, sensitive, and specific biomarkers of liver injury. Their usefulness in human liver transplantation, however, has not been addressed. The aim of this study was to investigate serum HDmiRs as markers of hepatic injury and rejection in liver transplantation. Serum samples from healthy controls and liver transplant recipients (n = 107) and peritransplant liver allograft biopsy samples (n = 45) were analyzed via the real-time polymerase chain reaction quantification of HDmiRs (miR-122, miR-148a, and miR-194). The expression of miR-122 and miR-148a in liver tissue was significantly reduced with prolonged graft warm ischemia times. Conversely, the serum levels of these HDmiRs were elevated in patients with liver injury and positively correlated with aminotransferase levels. HDmiRs appear to be very sensitive because patients with normal aminotransferase values (<50 IU/L) had 6- to 17-fold higher HDmiR levels in comparison with healthy controls (P < 0.005). During an episode of acute rejection, serum HDmiRs were elevated up to 20-fold, and their levels appeared to rise earlier than aminotransferase levels. HDmiRs in serum were stable during repeated freezing and thawing. In conclusion, this study shows that liver injury is associated with the release of HDmiRs into the circulation. HDmiRs are promising candidates as early, stable, and sensitive biomarkers of rejection and hepatic injury after liver transplantation.

摘要

最近的动物和人类研究强调了肝细胞衍生的 microRNAs(HDmiRs)在血清中作为肝损伤的早期、稳定、敏感和特异性生物标志物的潜力。然而,它们在人类肝移植中的应用尚未得到解决。本研究旨在探讨血清 HDmiRs 作为肝移植中肝损伤和排斥反应的标志物。通过实时聚合酶链反应定量分析 HDmiRs(miR-122、miR-148a 和 miR-194),分析了来自健康对照者和肝移植受者(n = 107)的血清样本和移植前肝移植肝活检样本(n = 45)。miR-122 和 miR-148a 在肝组织中的表达随着移植物热缺血时间的延长而显著降低。相反,这些 HDmiRs 的血清水平在肝损伤患者中升高,并与转氨酶水平呈正相关。HDmiRs 似乎非常敏感,因为转氨酶值正常(<50IU/L)的患者与健康对照者相比,HDmiR 水平高出 6-17 倍(P < 0.005)。在急性排斥反应发作期间,血清 HDmiRs 升高了 20 倍,其水平似乎比转氨酶水平更早升高。血清 HDmiRs 在反复冷冻和解冻过程中稳定。总之,本研究表明肝损伤与 HDmiRs 释放到循环中有关。HDmiRs 作为肝移植后排斥反应和肝损伤的早期、稳定和敏感的生物标志物具有很大的应用前景。

相似文献

1
Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation.肝细胞来源的 microRNAs 作为肝移植后肝损伤和排斥反应的血清标志物。
Liver Transpl. 2012 Mar;18(3):290-7. doi: 10.1002/lt.22438.
2
MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation.移植保存液中的 microRNA 谱可预测肝移植后缺血性胆管病变。
J Hepatol. 2013 Dec;59(6):1231-8. doi: 10.1016/j.jhep.2013.07.034. Epub 2013 Aug 6.
3
Plasma microRNA, a potential biomarker for acute rejection after liver transplantation.血浆 microRNA:肝移植后急性排斥反应的潜在生物标志物
Transplantation. 2013 Apr 27;95(8):991-9. doi: 10.1097/TP.0b013e31828618d8.
4
Hepatocyte-derived microRNAs as sensitive serum biomarkers of hepatocellular injury in Labrador retrievers.肝细胞源性微小RNA作为拉布拉多猎犬肝细胞损伤的敏感血清生物标志物
Vet J. 2016 May;211:75-81. doi: 10.1016/j.tvjl.2016.01.010. Epub 2016 Jan 18.
5
Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122.循环肝细胞来源 microRNA-122 对慢性丙型肝炎患者肝损伤的敏感检测。
J Viral Hepat. 2013 Mar;20(3):158-66. doi: 10.1111/jvh.12001. Epub 2012 Aug 27.
6
Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.血清 miR-122 作为慢性丙型肝炎病毒感染患者坏死性炎症的生物标志物。
Am J Gastroenterol. 2011 Sep;106(9):1663-9. doi: 10.1038/ajg.2011.161. Epub 2011 May 24.
7
Serum levels of interleukin-9 during acute rejection in liver transplantation.肝移植急性排斥反应期间的血清白细胞介素-9水平。
Transplant Proc. 2012 Jul-Aug;44(6):1533-5. doi: 10.1016/j.transproceed.2012.05.013.
8
Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation.肝移植急性排斥反应期间血清白细胞介素-17/白细胞介素-23水平的变化
Liver Transpl. 2009 Jun;15(6):629-33. doi: 10.1002/lt.21724.
9
High serum soluble CD30 does not predict acute rejection in liver transplant patients.高血清可溶性CD30不能预测肝移植患者的急性排斥反应。
Transplant Proc. 2006 Dec;38(10):3601-4. doi: 10.1016/j.transproceed.2006.10.063.
10
Serum alcohol dehydrogenase: a sensitive biomarker of ongoing graft function after liver transplantation.血清乙醇脱氢酶:肝移植后移植肝功能持续存在的敏感生物标志物。
Clin Transplant. 2007 Jul-Aug;21(4):498-501. doi: 10.1111/j.1399-0012.2007.00676.x.

引用本文的文献

1
Comprehensive characterization of the competitive endogenous RNA network revealing its immune-related functions in hepatic ischemia-reperfusion injury.竞争性内源性RNA网络的综合表征揭示其在肝缺血再灌注损伤中的免疫相关功能
PLoS One. 2025 Jul 24;20(7):e0327101. doi: 10.1371/journal.pone.0327101. eCollection 2025.
2
Diagnostic and predictive biomarkers of acute rejection after liver transplantation.肝移植术后急性排斥反应的诊断和预测生物标志物
Int J Surg. 2025 Jun 1;111(6):3908-3919. doi: 10.1097/JS9.0000000000002358. Epub 2025 Apr 3.
3
Heparinase I treatment to overcome RNA quantification interference in heparinized liver donor samples: One size fits all?
用肝素酶I处理以克服肝素化肝供体样本中RNA定量干扰:一刀切可行吗?
PLoS One. 2025 May 12;20(5):e0322899. doi: 10.1371/journal.pone.0322899. eCollection 2025.
4
Exosomal Biomarkers: A Comprehensive Overview of Diagnostic and Prognostic Applications in Malignant and Non-Malignant Disorders.外泌体生物标志物:恶性和非恶性疾病诊断及预后应用的全面概述
Biomolecules. 2025 Apr 15;15(4):587. doi: 10.3390/biom15040587.
5
Liver Transplantation for Non-hepatocellular Carcinoma: The Role of Immune Checkpoint Inhibitors.非肝细胞癌的肝移植:免疫检查点抑制剂的作用
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102558. doi: 10.1016/j.jceh.2025.102558. Epub 2025 Mar 27.
6
Differentially expressed microRNAs in pre-transplant lung biopsies target immune checkpoint proteins and can predict primary graft dysfunction in lung transplantation.移植前肺活检中差异表达的微小RNA靶向免疫检查点蛋白,并可预测肺移植中的原发性移植物功能障碍。
Heliyon. 2025 Feb 8;11(4):e42515. doi: 10.1016/j.heliyon.2025.e42515. eCollection 2025 Feb 28.
7
Understanding immunological insights of liver transplantation: a practice for attaining operational tolerance.理解肝移植的免疫学见解:实现手术耐受的实践。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae125.
8
Advancements in noninvasive techniques for transplant rejection: from biomarker detection to molecular imaging.移植排斥反应无创检测技术的进展:从生物标志物检测到分子成像
J Transl Med. 2025 Feb 3;23(1):147. doi: 10.1186/s12967-024-05964-4.
9
Physiological and cellular mechanisms of ischemic preconditioning microRNAs-mediated in underlying of ischemia/reperfusion injury in different organs.缺血预处理微小RNA介导不同器官缺血/再灌注损伤的生理和细胞机制
Mol Cell Biochem. 2025 Feb;480(2):855-868. doi: 10.1007/s11010-024-05052-7. Epub 2024 Jul 13.
10
Whole Exome Sequencing to Find Candidate Variants for the Prediction of Kidney Transplantation Efficacy.全外显子组测序寻找预测肾移植疗效的候选变异。
Genes (Basel). 2023 Jun 11;14(6):1251. doi: 10.3390/genes14061251.